395 related articles for article (PubMed ID: 22694921)
1. Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.
Wurtz N; Fall B; Pascual A; Diawara S; Sow K; Baret E; Diatta B; Fall KB; Mbaye PS; Fall F; Diémé Y; Rogier C; Bercion R; Briolant S; Wade B; Pradines B
Malar J; 2012 Jun; 11():197. PubMed ID: 22694921
[TBL] [Abstract][Full Text] [Related]
2. Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.
Fall B; Pascual A; Sarr FD; Wurtz N; Richard V; Baret E; Diémé Y; Briolant S; Bercion R; Wade B; Tall A; Pradines B
Malar J; 2013 Mar; 12():107. PubMed ID: 23510258
[TBL] [Abstract][Full Text] [Related]
3. Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea).
Berzosa P; Esteban-Cantos A; García L; González V; Navarro M; Fernández T; Romay-Barja M; Herrador Z; Rubio JM; Ncogo P; Santana-Morales M; Valladares B; Riloha M; Benito A
Malar J; 2017 Jan; 16(1):28. PubMed ID: 28086777
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan.
Ghanchi NK; Ursing J; Beg MA; Veiga MI; Jafri S; Mårtensson A
Malar J; 2011 Jan; 10():18. PubMed ID: 21272384
[TBL] [Abstract][Full Text] [Related]
5. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.
Ould Ahmedou Salem MS; Mint Lekweiry K; Bouchiba H; Pascual A; Pradines B; Ould Mohamed Salem Boukhary A; Briolant S; Basco LK; Bogreau H
Malar J; 2017 Apr; 16(1):140. PubMed ID: 28381273
[TBL] [Abstract][Full Text] [Related]
7. Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.
Dlamini SV; Beshir K; Sutherland CJ
Malar J; 2010 Mar; 9():68. PubMed ID: 20199676
[TBL] [Abstract][Full Text] [Related]
8. Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.
Gadalla NB; Abdallah TM; Atwal S; Sutherland CJ; Adam I
Malar J; 2013 Jul; 12():255. PubMed ID: 23870667
[TBL] [Abstract][Full Text] [Related]
9. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.
Kaingona-Daniel EP; Gomes LR; Gama BE; Almeida-de-Oliveira NK; Fortes F; Ménard D; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
Malar J; 2016 Jun; 15():309. PubMed ID: 27267365
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.
Yaqoob A; Khattak AA; Nadeem MF; Fatima H; Mbambo G; Ouattara A; Adams M; Zeeshan N; Takala-Harrison S
Malar J; 2018 Dec; 17(1):471. PubMed ID: 30558587
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
Koukouikila-Koussounda F; Bakoua D; Fesser A; Nkombo M; Vouvoungui C; Ntoumi F
Infect Genet Evol; 2015 Jul; 33():32-6. PubMed ID: 25934142
[TBL] [Abstract][Full Text] [Related]
12. Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers.
Koko VS; Warsame M; Vonhm B; Jeuronlon MK; Menard D; Ma L; Taweh F; Tehmeh L; Nyansaiye P; Pratt OJ; Parwon S; Kamara P; Asinya M; Kollie A; Ringwald P
Malar J; 2022 Apr; 21(1):134. PubMed ID: 35477399
[TBL] [Abstract][Full Text] [Related]
13. High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania.
Matondo SI; Temba GS; Kavishe AA; Kauki JS; Kalinga A; van Zwetselaar M; Reyburn H; Kavishe RA
Malar J; 2014 Apr; 13():152. PubMed ID: 24751352
[TBL] [Abstract][Full Text] [Related]
14. Stable high frequencies of sulfadoxine-pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine-pyrimethamine in Ujjain, Madhya Pradesh, India.
Pathak A; Mårtensson A; Gawariker S; Sharma A; Diwan V; Purohit M; Ursing J
Malar J; 2020 Aug; 19(1):290. PubMed ID: 32795288
[TBL] [Abstract][Full Text] [Related]
15. Characterization of drug resistance associated genetic polymorphisms among Plasmodium falciparum field isolates in Ujjain, Madhya Pradesh, India.
Pathak A; Mårtensson A; Gawariker S; Mandliya J; Sharma A; Diwan V; Ursing J
Malar J; 2014 May; 13():182. PubMed ID: 24885535
[TBL] [Abstract][Full Text] [Related]
16. Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India.
Rana R; Khan N; Sandeepta S; Pati S; Das A; Bal M; Ranjit M
Malar J; 2022 Dec; 21(1):394. PubMed ID: 36566182
[TBL] [Abstract][Full Text] [Related]
17. Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger.
Grais RF; Laminou IM; Woi-Messe L; Makarimi R; Bouriema SH; Langendorf C; Amambua-Ngwa A; D'Alessandro U; Guérin PJ; Fandeur T; Sibley CH
Malar J; 2018 Feb; 17(1):98. PubMed ID: 29486766
[TBL] [Abstract][Full Text] [Related]
18. Analysis of sulphadoxine/pyrimethamine resistance-conferring mutations of Plasmodium falciparum from Mozambique reveals the absence of the dihydrofolate reductase 164L mutant.
Fernandes N; Figueiredo P; do Rosário VE; Cravo P
Malar J; 2007 Mar; 6():35. PubMed ID: 17378942
[TBL] [Abstract][Full Text] [Related]
19. Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran.
Afsharpad M; Zakeri S; Pirahmadi S; Djadid ND
Acta Trop; 2012 Jan; 121(1):13-8. PubMed ID: 22001304
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of artesunate + sulphadoxine/pyrimethamine and artemether + lumefantrine and dhfr and dhps mutations in Somalia: evidence for updating the malaria treatment policy.
Warsame M; Hassan AH; Hassan AM; Arale AM; Jibril AM; Mohamud SA; Barrette A; Muse AY; Yusuf FE; Nada RA; Amran JG
Trop Med Int Health; 2017 Apr; 22(4):415-422. PubMed ID: 28151566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
